A clearstate report

Going global: opportunities for Chinese IVD companies

Overseas markets are making up an increasingly larger share of the revenue of Chinese IVD companies. 

Opportunistic growth opportunities from covid-19 have helped fuel rapid growth for Chinese companies not just domestically, but also in overseas markets. However, according to data from Clearstate’s IVD Gateway, in the first half of 2022 growth rate has slowed compared with 2021, indicating the difficulty in sustaining growth.

As global demand for covid-19 testing cools, how can Chinese IVD companies continue to thrive in overseas markets? This report identifies core areas of growth in global markets—in particular, emerging markets in Asia Pacific, Latin America and the Middle East where there are promising opportunities for IVD companies to expand.